Skip to main content
Fig. 1 | Trials

Fig. 1

From: Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial

Fig. 1

The clinical research flow chart. Explanatory footnotes: The number of participants enrolled in the screening phase (n = 6000) is an estimate to yield n = 3000 randomised. Screened participants eligible for the RCT or cohort study will be consecutively recruited. Follow-up will consist of 4-monthly scheduled visits for the first 24 months and inter-lock with routine DM clinic care after 24 months. Details of the sub-studies are not provided in this trial protocol paper

Back to article page

Trials

ISSN: 1745-6215